» Articles » PMID: 33777949

CaMKIIδ Splice Variants in the Healthy and Diseased Heart

Overview
Specialty Cell Biology
Date 2021 Mar 29
PMID 33777949
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

RNA splicing has been recognized in recent years as a pivotal player in heart development and disease. The Ca/calmodulin dependent protein kinase II delta (CaMKIIδ) is a multifunctional Ser/Thr kinase family and generates at least 11 different splice variants through alternative splicing. This enzyme, which belongs to the CaMKII family, is the predominant family member in the heart and functions as a messenger toward adaptive or detrimental signaling in cardiomyocytes. Classically, the nuclear CaMKIIδB and cytoplasmic CaMKIIδC splice variants are described as mediators of arrhythmias, contractile function, Ca handling, and gene transcription. Recent findings also put CaMKIIδA and CaMKIIδ9 as cardinal players in the global CaMKII response in the heart. In this review, we discuss and summarize the new insights into CaMKIIδ splice variants and their (proposed) functions, as well as CaMKII-engineered mouse phenotypes and cardiac dysfunction related to CaMKIIδ missplicing. We also discuss RNA splicing factors affecting CaMKII splicing. Finally, we discuss the translational perspective derived from these insights and future directions on CaMKIIδ splicing research in the healthy and diseased heart.

Citing Articles

Development and disease-specific regulation of RNA splicing in cardiovascular system.

Jiang J, Wu H, Ji Y, Han K, Tang J, Hu S Front Cell Dev Biol. 2024; 12:1423553.

PMID: 39045460 PMC: 11263117. DOI: 10.3389/fcell.2024.1423553.


Posttranscriptional Regulation by Proteins and Noncoding RNAs.

Aranega A, Franco D Adv Exp Med Biol. 2024; 1441:313-339.

PMID: 38884719 DOI: 10.1007/978-3-031-44087-8_17.


Quantitative proteomics reveals CLR interactome in primary human cells.

Manolis D, Hasan S, Maraveyas A, OBrien D, Kessler B, Kramer H J Biol Chem. 2024; 300(6):107399.

PMID: 38777147 PMC: 11231609. DOI: 10.1016/j.jbc.2024.107399.


The Regulatory Effect of Receptor-Interacting Protein Kinase 3 on CaMKIIδ in TAC-Induced Myocardial Hypertrophy.

Qian J, Zhang J, Cao J, Wang X, Zhang W, Chen X Int J Mol Sci. 2023; 24(19).

PMID: 37833985 PMC: 10572717. DOI: 10.3390/ijms241914529.


Applications of Genome Editing Technologies in CAD Research and Therapy with a Focus on Atherosclerosis.

Mak M, Gurung R, Foo R Int J Mol Sci. 2023; 24(18).

PMID: 37762360 PMC: 10531628. DOI: 10.3390/ijms241814057.


References
1.
Parikh V, Caleshu C, Reuter C, Lazzeroni L, Ingles J, Garcia J . Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy. Circ Heart Fail. 2019; 12(3):e005371. PMC: 6422044. DOI: 10.1161/CIRCHEARTFAILURE.118.005371. View

2.
Refaat M, Lubitz S, Makino S, Islam Z, Frangiskakis J, Mehdi H . Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy. Heart Rhythm. 2011; 9(3):390-6. PMC: 3516872. DOI: 10.1016/j.hrthm.2011.10.016. View

3.
Rinaldi C, Wood M . Antisense oligonucleotides: the next frontier for treatment of neurological disorders. Nat Rev Neurol. 2017; 14(1):9-21. DOI: 10.1038/nrneurol.2017.148. View

4.
Ljubojevic-Holzer S, Herren A, Djalinac N, Voglhuber J, Morotti S, Holzer M . CaMKIIδC Drives Early Adaptive Ca Change and Late Eccentric Cardiac Hypertrophy. Circ Res. 2020; 127(9):1159-1178. PMC: 7547876. DOI: 10.1161/CIRCRESAHA.120.316947. View

5.
Zhu W, Woo A, Yang D, Cheng H, Crow M, Xiao R . Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J Biol Chem. 2007; 282(14):10833-9. DOI: 10.1074/jbc.M611507200. View